Skip to main content Skip to navigation

Antiviral Technology

Research on the molecular mechanisms of viruses is enabling us to develop new technologies to treat infectious diseases such as influenza.

Antiviral Technology  A new broad-spectrum antiviral
Viruses present an ongoing present and future threat to mankind. Few antiviral drugs or treatments have reached the clinic and virus resistance, as with all microorganisms, is a major problem where antivirals have been deployed. We have discovered how to harness a new generation of naturally-occurring antivirals produced by influenza A virus. One in particular, VH244, is highly active in preclinical tests against many different influenza A viruses, and also against other unrelated respiratory viruses. The next step is human testing in clinical trials.